Mwangi wa Mutahi

Statistics

Publications

Citations

H-Index

Active since

1998

Affiliations

Mwangi wa Mutahi is an author at AGCO (United Kingdom) specializing in histamine receptor antagonists, histamine receptor pharmacology, and histamine receptor antagonism.

Publications per year

1998–2005

Publications

Identification of a dual histamine H1/H3 receptor ligand based on the H1 antagonist chlorpheniramine

Robert Aslanian, Mwangi wa Mutahi, Neng‐Yang Shih et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 33 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12

Identification of a novel, orally bioavailable histamine H3 receptor antagonist based on the 4-benzyl-(1H-imidazol-4-yl) template

Robert Aslanian, Mwangi wa Mutahi, Neng‐Yang Shih et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 27 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Reduction of CYP450 inhibition in the 4-[(1H-imidazol-4-yl)methyl]piperidine series of histamine H3 receptor antagonists

Michael Berlin, Pauline C. Ting, Wayne Vaccaro et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 16 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +11

4- [(1H - imidazol - 4 - YL) methyl] benzamidines and benzylamidines: novel antagonists of the histamine H3 receptor

Robert Aslanian, Joan E. Brown, N.‐Y. SHIH et al. · Bioorganic & Medicinal Chemistry Letters · 1998 · 14 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +11

1–4 of 4